LobbyingVizient lobbying by quarter
Vizient's latest lobbying report covers Q4 2023, at $40K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Vizient
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $40K | 1 |
| Q1 2023 | $40K | 1 |
| Q2 2023 | $40K | 1 |
| Q3 2023 | $40K | 1 |
| Q4 2023 | $40K | 1 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$200K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES5 reports
- SENATE5 reports
- Health & Human Services, Dept of (HHS)1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Correia & Osolinik | $200K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/02/27for Q4 2023 | Correia & Osolinik | $40K |
| 23/11/03for Q3 2023 | Correia & Osolinik | $40K |
| 23/08/30for Q2 2023 | Correia & Osolinik | $40K |
| 23/06/06for Q1 2023 | Correia & Osolinik | $40K |
| 23/02/23for Q4 2022 | Correia & Osolinik | $40K |